期刊
AMERICAN JOURNAL OF HYPERTENSION
卷 34, 期 1, 页码 73-81出版社
OXFORD UNIV PRESS
DOI: 10.1093/ajh/hpaa142
关键词
blood brain barrier; blood pressure; eclampsia; hypertension; in vitro studies; PlGF; preeclampsia; sFlt-1; VEGFR2
资金
- Swedish Society of Medical Research (SSMF)
- Fondecyt [1200250, 3190475]
- Swedish Society of Medicine [SLS-878741]
- Uppsala University Hospital Research Found
In this study, researchers used an in vitro model of the human blood-brain barrier to investigate the role of VEGFR2 in preeclampsia. They found that selective tyrosine phosphorylation of VEGFR2 may contribute to the increased BBB permeability in preeclampsia, regardless of plasma concentrations of angiogenic biomarkers.
BACKGROUND Cerebral complications in preeclampsia are leading causes of maternal mortality worldwide but pathophysiology is largely unknown and a challenge to study. Using an in vitro model of the human blood-brain barrier (BBB), we explored the role of vascular endothelial growth factor receptor 2 (VEGFR2) in preeclampsia. METHODS The human brain endothelial cell line (hCMEC/D3) cultured on Tranwells insert was exposed (12 hours) to plasma from women with preeclampsia (n = 28), normal pregnancy (n = 28), and nonpregnant (n = 16) controls. Transendothelial electrical resistance (TEER) and permeability to 70 kDa fluorescein isothiocyanate (FITC)-dextran were measured for the assessment of BBB integrity. We explored possible underlying mechanisms, with a focus on the expression of tight junction proteins and phosphorylation of 2 tyrosine residues of VEGFR2, associated with vascular permeability and migration (pY951) and cell proliferation (pY1175). Plasma concentrations of soluble FMS-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) were also measured. RESULTS hCMEC/D3 exposed to plasma from women with preeclampsia exhibited reduced TEER and increased permeability to 70 kDa FITC-dextran. These cells upregulated the messenger ribonucleic acid (mRNA) levels of VEGFR2, and pY951-VEGFR2, but reduced pY1175-VEGFR2 (P < 0.05 in all cases). No difference in mRNA expression of tight junction protein was observed between groups. There was no correlation between angiogenic biomarkers and BBB permeability. CONCLUSIONS We present a promising in vitro model of the BBB in preeclampsia. Selective tyrosine phosphorylation of VEGFR2 may participate in the increased BBB permeability in preeclampsia irrespective of plasma concentrations of angiogenic biomarkers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据